Skip to main navigation Skip to search Skip to main content

Ph 3, multicter, randmizd, d-blind, plac-control study to assess the efficacy, safety, and tolerability of AVP-786 (deudextromethorphan hydrobromide [d6-DM]/quinidine sulfate [Q]) for the tx of agitation in patients with dementia of the A

Project: Research

Project Details

StatusFinished
Effective start/end date05/24/2101/31/26

Funding

  • Otsuka America Pharmaceutical Incorporated: $29,205.00